Similar articles for PMID: 15342696

Year	Number of Results
1994	2
1995	2
1996	1
1998	1
1999	2
2000	7
2001	2
2002	1
2003	4
2004	7
2005	11
2006	5
2007	8
2008	5
2010	5
2011	2
2012	2
2013	4
2014	3
2015	3
2016	2
2017	6
2018	5
2019	2
2020	1
2021	3
2024	0

1

BRAF screening as a low-cost effective strategy for simplifying HNPCC genetic testing.

Domingo E, Laiho P, Ollikainen M, Pinto M, Wang L, French AJ, Westra J, Frebourg T, Espín E, Armengol M, Hamelin R, Yamamoto H, Hofstra RM, Seruca R, Lindblom A, Peltomäki P, Thibodeau SN, Aaltonen LA, Schwartz S Jr. Domingo E, et al. J Med Genet. 2004 Sep;41(9):664-8. doi: 10.1136/jmg.2004.020651. J Med Genet. 2004. PMID: 15342696 Free PMC article.

2

Incorporation of somatic BRAF mutation testing into an algorithm for the investigation of hereditary non-polyposis colorectal cancer.

Loughrey MB, Waring PM, Tan A, Trivett M, Kovalenko S, Beshay V, Young MA, McArthur G, Boussioutas A, Dobrovic A. Loughrey MB, et al. Fam Cancer. 2007;6(3):301-10. doi: 10.1007/s10689-007-9124-1. Epub 2007 Apr 24. Fam Cancer. 2007. PMID: 17453358

3

BRAF-V600E is not involved in the colorectal tumorigenesis of HNPCC in patients with functional MLH1 and MSH2 genes.

Domingo E, Niessen RC, Oliveira C, Alhopuro P, Moutinho C, Espín E, Armengol M, Sijmons RH, Kleibeuker JH, Seruca R, Aaltonen LA, Imai K, Yamamoto H, Schwartz S Jr, Hofstra RM. Domingo E, et al. Oncogene. 2005 Jun 2;24(24):3995-8. doi: 10.1038/sj.onc.1208569. Oncogene. 2005. PMID: 15782118

4

Frequency and application of the hot spot BRAF gene mutation (p.V600E) in the diagnostic strategy for Hereditary Nonpolyposis Colorectal Cancer.

Kadiyska TK, Konstantinova DV, Atanasov VR, Kremensky IM, Mitev VI. Kadiyska TK, et al. Cancer Detect Prev. 2007;31(3):254-6. doi: 10.1016/j.cdp.2007.04.001. Epub 2007 Jun 12. Cancer Detect Prev. 2007. PMID: 17566669

5

Detection of BRAF V600E mutation in colorectal cancer: comparison of automatic sequencing and real-time chemistry methodology.

Benlloch S, Payá A, Alenda C, Bessa X, Andreu M, Jover R, Castells A, Llor X, Aranda FI, Massutí B. Benlloch S, et al. J Mol Diagn. 2006 Nov;8(5):540-3. doi: 10.2353/jmoldx.2006.060070. J Mol Diagn. 2006. PMID: 17065421 Free PMC article.

6

Promoter hypermethylation frequency and BRAF mutations distinguish hereditary non-polyposis colon cancer from sporadic MSI-H colon cancer.

McGivern A, Wynter CV, Whitehall VL, Kambara T, Spring KJ, Walsh MD, Barker MA, Arnold S, Simms LA, Leggett BA, Young J, Jass JR. McGivern A, et al. Fam Cancer. 2004;3(2):101-7. doi: 10.1023/B:FAME.0000039861.30651.c8. Fam Cancer. 2004. PMID: 15340260

7

Detection of occult high graded microsatellite instabilities in MMR gene mutation negative HNPCC tumors by addition of complementary marker analysis.

Schiemann U, Müller-Koch Y, Gross M, Glas J, Baretton G, Muders M, Mussack T, Holinski-Feder E. Schiemann U, et al. Eur J Med Res. 2005 Jan 28;10(1):23-8. Eur J Med Res. 2005. PMID: 15737950

8

Identification in daily practice of patients with Lynch syndrome (hereditary nonpolyposis colorectal cancer): revised Bethesda guidelines-based approach versus molecular screening.

Julié C, Trésallet C, Brouquet A, Vallot C, Zimmermann U, Mitry E, Radvanyi F, Rouleau E, Lidereau R, Coulet F, Olschwang S, Frébourg T, Rougier P, Nordlinger B, Laurent-Puig P, Penna C, Boileau C, Franc B, Muti C, Hofmann-Radvanyi H. Julié C, et al. Am J Gastroenterol. 2008 Nov;103(11):2825-35; quiz 2836. doi: 10.1111/j.1572-0241.2008.02084.x. Epub 2008 Aug 27. Am J Gastroenterol. 2008. PMID: 18759827

9

Prediction of a mismatch repair gene defect by microsatellite instability and immunohistochemical analysis in endometrial tumours from HNPCC patients.

de Leeuw WJ, Dierssen J, Vasen HF, Wijnen JT, Kenter GG, Meijers-Heijboer H, Brocker-Vriends A, Stormorken A, Moller P, Menko F, Cornelisse CJ, Morreau H. de Leeuw WJ, et al. J Pathol. 2000 Nov;192(3):328-35. doi: 10.1002/1096-9896(2000)9999:9999<::AID-PATH701>3.0.CO;2-2. J Pathol. 2000. PMID: 11054716

10

Concomitant RASSF1A hypermethylation and KRAS/BRAF mutations occur preferentially in MSI sporadic colorectal cancer.

Oliveira C, Velho S, Domingo E, Preto A, Hofstra RM, Hamelin R, Yamamoto H, Seruca R, Schwartz S Jr. Oliveira C, et al. Oncogene. 2005 Nov 17;24(51):7630-4. doi: 10.1038/sj.onc.1208906. Oncogene. 2005. PMID: 16007118

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

89 results

Results by year